Visit day | Pre-screen | Day 1 baseline | 3 M | 6 M | 9 M | 12 M | 15 M | 18 M | 21 M | 24 M | 27 M | 30 M | 33 M | 36 M |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Visit Window | ± 2 weeks | ± 2 weeks | ± 2 weeks | ± 2 weeks | ± 2 weeks | ± 2 weeks | ± 2 weeks | ± 2 weeks | ± 2 weeks | ± 2 weeks | ± 2 weeks | ± 2 weeks | ||
Check eligibility | x | x | ||||||||||||
Informed consent | x | |||||||||||||
Demographic data | x | |||||||||||||
Medical history | x | |||||||||||||
Dialysis history | x | |||||||||||||
Sociodemographic history | x | |||||||||||||
Randomise | x | |||||||||||||
Blood test results1 | x | x | x | x | x | x | x | x | x | x | x | x | x | x |
Additional iron studies pathology2, 3 | x | x | x | |||||||||||
MRI scan (FerriScan)3 | x | x | ||||||||||||
Ultrasound/FibroScan of the liver 4 | x | x | ||||||||||||
Clinical outcomes data collection | x | x | x | x | x | x | x | x | x | x | x | x | ||
Vital status (alive) | x | x | x | x | x | x | x | x | x | x | x | x | x | |
Procedures | x | x | x | x | x | x | x | x | x | x | x | x | x | |
Hospitalisations | x | x | x | x | x | x | x | x | x | x | x | x | x | |
Concomitant medication | x | x | x | x | x | x | x | x | x | x | x | x | x | |
Adverse events | x | x | x | x | x | x | x | x | x | x | x | x | x |